Thomas Reilly
Director of Finance/CFO presso AMARIN CORPORATION PLC
Patrimonio netto: 191 890 $ in data 31/03/2024
Profilo
Thomas Reilly is currently the CFO, Executive VP, Head-Global HR & Finance at Amarin Corp.
Plc.
Previously, he worked as the Head-Finance Medicines Business at Allergan, Inc. and as the Chief Financial & Accounting Officer at CARA Therapeutics, Inc. He completed his undergraduate degree at Manhattan College and holds an MBA from Seton Hall University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
AMARIN CORPORATION
0.06% | 20/02/2024 | 215 365 ( 0.06% ) | 191 890 $ | 31/03/2024 |
Posizioni attive di Thomas Reilly
Società | Posizione | Inizio |
---|---|---|
AMARIN CORPORATION PLC | Director of Finance/CFO | 20/06/2022 |
Precedenti posizioni note di Thomas Reilly
Società | Posizione | Fine |
---|---|---|
CARA THERAPEUTICS, INC. | Director of Finance/CFO | 15/06/2022 |
ALLERGAN, INC. | Corporate Officer/Principal | - |
Formazione di Thomas Reilly
Manhattan College | Undergraduate Degree |
Seton Hall University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
AMARIN CORPORATION PLC | Health Technology |
CARA THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
- Borsa valori
- Insiders
- Thomas Reilly